Shiba Inu Burn Rate Explodes 49,646% as SHIB Price Climbs 10% in Stunning Market Rally 
XRP Soars as Trump’s Pro-Crypto Treasury Pick Gains Ripple CEO’s Approval 
Shiba Inu Whales Dominate Market With $300M in Transactions Despite 9% Price Drop 
Shiba Inu in Trouble? 33 Trillion SHIB Could Fall If $0.000022 Support Breaks 
Arthur Hayes Drives Solana Meme Coin Rally, FlowerAI’s Market Cap Jumps $8M After Social Media Post 
Crypto Rules Shakeup: Trump-Tied SEC Candidate Hints at Clearer Path After Gensler’s Sudden Exit 
Understanding Self-Exclusion Programs: Your Guide to Responsible Gaming 
OpenAI, Samsung Talks Signal a Major Shift for Galaxy Devices, Threatening Google’s AI Stronghold 
Xiaomi's Second Electric SUV to Challenge Tesla Model Y in Q1 2025, Report Reveals 
Stellar Jumps 80% to $0.55 as Grayscale Trust Adds Millions—Is $1 Within Reach? 
Cardano Hits $1.06 Milestone as Experts Eye $6 and Beyond in Bullish Breakout 
Solana Hits $262 ATH Amid $35M Whale Buys—Could $5,000 Be Next? 
Ethereum's Path to $20K: Correction Likely First, Analysts Warn 
Rachel Maddow’s Shocking Pay Cut: MSNBC Staffers Reportedly ‘Panicking’ Over Network’s Future 
Why Monday is the most dangerous day on a building site 
Shiba Inu Sends Urgent Scam Alert Amid 12% Price Spike: Details Unveiled 
Bitcoin Targets $180K in 2025, TYMIO Founder Predicts Supply Shock 
Orion Group purchased a controlling stake in LegoChem Biosciences, a South Korean research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines. The confectionery company is acquiring a 25.7% stake worth KRW550 billion or around $418 million.
With the size of its acquisition, the Orion Group has now become the largest shareholder of LegoChem Biosciences. The firm made the deal as it seeks to broaden its business and enter into new drug development business beyond antibody-drug conjugate platform technology, as per the Korea Joongang Daily.
What is Included in the Agreement
Pan Orion Corporation, the Hong Kong-headquartered subsidiary of the Orion Group, led the acquisition deal. Based on the reports, the agreement includes a combination of share purchases and rights offerings.
Moreover, it was stated in the electronic disclosure of the Financial Supervisory Service that Orion will buy 7.96 million units of new stakes at KRW59,000 per share. In addition, it will also purchase 1.4 million existing shares at the base rate of 56,186 per share. Orion is scheduled to settle the payment for the acquisition on March 29.
Orion's Venture Into Biotech Business
The Korea Economic Daily reported that this buyout deal not only marks the Orion Group's deeper venture into the biotech industry but is also expected to help the company in achieving its goal of giving a boost to LegoChem Biosciences by providing the needed financial push for clinical development and encouraging new technology research.
Once the deal is completed, Orion will be the largest shareholder in LegoChem Biosciences. Currently, the company's chief executive officer, Kim Yong Zu, holds the biggest share, and after the acquisition, he will still retain some of his shares and keep his CEO position. LegoChem is also set to become one of the confectionery giant's affiliates.
Photo by: Orion Website
